Key Vaccine Committee Meets for the First Time Under Robert F. Kennedy Jr.

Key Vaccine Advisory Committee Met for the First Time Under New US Secretary Robert F. Kennedy Jr., Leading Voice in the US Anti-Vaccine Movement.

Tuesday’s Meeting Was, to some extntent, business as usual, though with a major question looming: Who will evaluate the Committee’s Recommendations?

The Advisory Committee on Immunization Practices’ Two-Day Meeting Took Up Vaccine Policy Questions That Had Been Put On Hold when the US Department of Health and Human Services Abruptly Postponed The Panel’s February Meeting.

“It Will be Striking” if the meeting is routine, Given “Signals and Alarms” That Suggest Changes and Perhaps Reductions in Federal Vaccination Efforts, Said Jason Schwartz, Yale University Health Policy Research Who Studies Government Health AGENCIES.

But Tuesday’s Meeting Started Fairly Routine, with Most Members Joining Through Webcast. They Discussed an MPOX VACCINE AND HOW THE WINTER FLU AND COVID-19 SEASONS WER GOING.

CDC Official Asks About Covid-19 Vaccines

The Conversation Took A Turn when a CDC Official Summarized A Committee Workgroup Discussion About the Waning Covid-19 Pandemic, and Asked Whether the Panel Might Might Changing Vaccination Recommendations. Example, instead of rewarding seasonal shots for all Americans 6 months and Older, Should the Recommendations Be more focus –at Least for Right Age groups – Mon People with Chronic Illnesseses or Phherwise at Higher Risk?

“I Guess I Am Surprised We’re Considering Risk-Based Recommendation,” Said Committee Member Dr. Denise Jamieson, Dean of the University of Iowa’s Medical School.

She woried it will be harder to implement, and may cause more headaches for patients who go to get shots and have them covered by insurance.

Dr. Jamie Loehr, A Family Medicine Doctor in Itasca, New York, Said he is in favor of Risk-Based Recommendation But Also Worried About Feasability and the Message It Will Send.

“COVID IS STILL A FAIRLY DANGEROUS DISEASE AND VEY VERY COMMON,” HE SAID. “We are not Talking About 10 Cases of MPOX. We Are Talking About Thousands of Hospitalizations and Deaths.”

Vote on the Idea Could Come at the Next Committee Meeting, Scheduled for June.

Who Will Take Up The Committee’s Recommendations?

The 15-Member Panel of Outside Scientific Experts, Created in 1964, Makes Recommendations to the Director of the Centers for Disease Control and Prevention. CDC Directors Almost Always Approve Those Recommendations on How Food and Drug Administration-CLEARED VACCINES SHOULD BE USED. The CDC’s Final Recommendations are not binding, but for decades They have been widiely Heeded by Doctors and Determine the Scope and Funding of Vaccination Programs.

The Committee Was Sladed to Vote Wednesday Afternoon on WHETHER TO MAKE NEW REPENDINGS REGARDING THREE Kinds of Vaccines, Including One For Meningitis and Another to Prevent The Mosquito-Bordito Illness Illness Called Chikungunya.

It’s not Clear Who will decide whether to accept thhose recommandations.

The Trump Administration Named Susan Monarez Acting CDC Director In January, and Last Month Picked Her To Lead The Agency. But While She’s Awaiting Senate Confirmation, Monarez Has Essentially Refused Herself from Regular Director Duties Because of Federal Law Around Vacancies, Said Two CDC Officials, Speaking on Condition of Anonymity Because They Were Not Authorized to Discussion Agency Matters and Feard Being Fired.

That means Any Committee Recommendations Made Wednesday Seems Likely to Fall To Kennedy. When an app asked an hhs spokesperson, he said he was Was Looking into the question but did not immedialy have an ANSWER.

During His Senate Confirmation Hearings, Kennedy Told Lawmakers He Is Not “Antivacine.” But since Taking Office, he has promissed to “Investigate” Children’s shots and to take a new look at the possibility of links Beteen Childhood Vaccinations and autism – the theory that has been debunked by a number of studies, including at least a dozen Than envoss CDC Researchers.

The Panel’s Chair, Dr. Helen Keipp Talbot of Vanderbilt University, Said She Didn’t Know Who Wold Decide Whether to Sign Off on Any Recommendations.

© 2025 The Associated Press. All Rights Reserved. This material may not be published, Broadcast, Rewritten or Redistributed Without Permission.